Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples